Drug Development Solutions is a contract research organisation (CRO) offering GLP and GCP bioanalysis of small molecules, large proteins for pharmacokinetics, biomarkers and immunogenicity. We also provide cGMP analytical sciences research and testing services, consultancy and quality control solutions to support Chemistry Manufacturing and Control (CMC) requirements at all stages of the drug development pipeline from discovery through preclinical and clinical development to commercial manufacture.

Our Cambridge (Fordham) site is one of the largest bioanalytical centres in the world. The site employs around 380 scientists operating from 8,000m2 purpose-built, state-of-the-art analytical labs.